Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease

Front Aging Neurosci. 2022 May 5:14:908716. doi: 10.3389/fnagi.2022.908716. eCollection 2022.

Shereen Nizari^{1

2}, Cheryl A Hawkes³, Yorito Hattori⁴, Anusha Mishra^{5

6}

¹ Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, United Kingdom.
² Centre for Cardiovascular and Metabolic Neuroscience, Department of Neuroscience, Physiology & Pharmacology, University College London, London, United Kingdom.
³ Department of Biomedical and Life Sciences, Lancaster University, Lancaster, United Kingdom.
⁴ Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Japan.
⁵ Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, United States.
⁶ Department of Neurology, Jungers Center for Neurosciences Research, Oregon Health & Science University, Portland, OR, United States.

No abstract available

Keywords: biomarker; cerebral blood flow (CBF); cerebrovascular disease; neurovascular unit (NVU); therapeutic target.

Publication types